PMID: 25522986

Zannis VI, Fotakis P, Koukos G, Kardassis D, Ehnholm C, Jauhiainen M, Chroni A
HDL biogenesis, remodeling, and catabolism.
Handb Exp Pharmacol. 2015;224:53-111. doi: 10.1007/978-3-319-09665-0_2., [PubMed]
Sentences
No. Mutations Sentence Comment
50 ABCA1 p.Trp590Ser
X
ABCA1 p.Trp590Ser 25522986:50:33
status: NEW
view ABCA1 p.Trp590Ser details
A notable exemption is the ABCA1[W590S] mutant which cross-linked stronger to apoA-I than to WT ABCA1 but had diminished capacity to promote cholesterol efflux and to promote formation of HDL (Bodzioch et al. 1999; Fitzgerald et al. 2001, 2002). Login to comment
76 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:76:188
status: NEW
view ABCA1 p.Leu222Ala details
Adenovirus-mediated gene transfer of these mutants in apoA-I / x apoE / mice (Fotakis et al. 2013a, b) showed that compared to the WT apoA-I, the expression of an apoA-I[L218A/L219A/V221A/L222A] mutant decreased plasma cholesterol, apoA-I, and HDL cholesterol levels and generated preb2;- and b1;4 HDL subpopulations (Fotakis et al. 2013a) (Table 1 and Fig. 3a-g). Login to comment
77 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:77:144
status: NEW
view ABCA1 p.Leu222Ala details
To eliminate the involvement of apoE in the generation of apoE-containing HDL particles (Kypreos and Zannis 2007), the apoA-I[L218A/L219A/V221A/L222A] mutant was expressed in apoA-I / x apoE / mice via adenovirus-mediated gene transfer (Fotakis et al. 2013a). Login to comment
81 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:81:382
status: NEW
view ABCA1 p.Leu222Ala details
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:81:532
status: NEW
view ABCA1 p.Leu222Ala details
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:81:617
status: NEW
view ABCA1 p.Leu222Ala details
Table 1 Plasma lipids and hepatic mRNA levels of apoA-I / or apoA-I / x apoE / mice expressing WT and mutant forms of apoA-I in the presence and absence of LCAT as indicated Protein expressed Total cholesterol (mg/dL) Triglycerides (mg/dL) Relative apoA-I mRNA (%) apoA-I plasma levels (mg/dL) WT apoA-I in apoA-I / mice 278  74 78  24 100  26 260  40 apoA-I[L218A/L219A/V221A/ L222A] in apoA-I / mice 45  14 50  20 95  24 41  5 WT apoA-I in apoA-I / x apoE / mice 1,343  104 294  129 100  13 - apoA-I[L218A/L219A/V221A/ L222A] in apoA-I / x apoE / mice 778  52 18  2 92  23 - apoA-I[L218A/L219A/V221A/ L222A] plus LCAT in apoA-I / x apoE / mice 754  122 37  10 90  3 - Fig. 3 (a-g) ApoA-I mutations and their effect on the HDL phenotypes. Login to comment
82 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:82:130
status: NEW
view ABCA1 p.Leu222Ala details
Analysis of plasma of apoA-I / x apoE / mice infected with adenoviruses expressing the WT apoA-I or the apoA-I [L218A/L219A/V221A/L222A] mutant, as indicated, by density gradient ultracentrifugation and SDS-PAGE (a, e). Login to comment
83 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:83:127
status: NEW
view ABCA1 p.Leu222Ala details
EM analysis of HDL fractions 6-7 obtained from apoA-I / x apoE / mice expressing the WT apoA-I or the apoA-I[L218A/L219A/V221A/L222A] mutant, as indicated, following density gradient ultracentrifugation of plasma (b, f). Login to comment
85 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:85:152
status: NEW
view ABCA1 p.Leu222Ala details
Two-dimensional gel electrophoresis of plasma of apoA-I / x apoE / mice infected with adenoviruses expressing WT apoA-I or the apoA-I[L218A/L219A/V221A/L222A] mutant, as indicated (d, g) These particles may originate from apoB-48 containing lipoproteins that are found in the HDL fractions (Fig. 3c). Login to comment
88 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:88:46
status: NEW
view ABCA1 p.Leu222Ala details
Co-expression of the apoA-I[L218A/L219A/V221A/L222A] mutant and human LCAT in apoA-I / x apoE / mice did not correct the plasma apoA-I levels and did not correct the aberrant HDL phenotype. Login to comment
92 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:92:55
status: NEW
view ABCA1 p.Leu222Ala details
The phenotype produced by the apoA-I[L218A/L219A/V221A/L222A] mutations is distinct from all previously described phenotypes and cannot be corrected by overexpression of LCAT. Login to comment
94 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:94:137
status: NEW
view ABCA1 p.Leu222Ala details
Although other interpretations are possible, the in vivo and in vitro data suggest that the interaction of the apoA-I [L218A/L219A/V221A/L222A] mutant with ABCA1 results in defective lipidation of apoA-I that leads to the generation of preb2;-HDL particles that are not a good substrate for LCAT. Login to comment
99 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:99:153
status: NEW
view ABCA1 p.Leu222Ala details
The phenotype generated by the expression of the apoA-I[F225A/V227A/ F229A/L230A] mutant was similar to that obtained with the apoA-I[L218A/ L219A/V221A/L222A] mutant. Login to comment
421 ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:421:95
status: NEW
view ABCA1 p.Leu222Ala details
ApoA-I mutants with defective C-terminal apoA-I[Ɗ(185-243)] and apoA-I[L218A/L219A/V221A/ L222A] had 80 % decreased specific binding and 90 % decreased specific transport by aortic endothelial cells. Login to comment